Efficient Foreign Gene Expression in Epstein-Barr Virus-Transformed Human B-Cells

Virology

Volumn 198, Issue 2, 1994, Pages 577-585

  Curiel, Tyler J ^a   Cook, Deborah R ^a   Bogedain, Christoph ^b   Jilg, Wolfgang ^b   Harrison, Gail S ^c   Cotten, Matt ^d   Curiel, David T ^d   Wagner, Ernst ^d  

^a Divisions of infectious Disease and University of Colorado Health Sciences Center ^*  (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; ARTICLE; B LYMPHOCYTE; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; IN VITRO EXPRESSION SYSTEM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION;

ANIMAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENES, REPORTER; GENETIC VECTORS; HERPESVIRUS 4, HUMAN; HIV; HUMAN; MALE; MICE; MICE, SCID; PROMOTER REGIONS (GENETICS); RECEPTORS, FC; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; VIRAL PROTEINS;

EID: 0028360097     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1006/viro.1994.1069     Document Type: Article

References (40)

1. Abrahamson, D. R., and Rodewald, R. (1981). Evidence for the sorting of endocytic vesicle contents during the receptor-mediated transport of IgG across the newborn rat intestine. J. Cell Bio, 91, 270-260.
2. Cann, A. J., Koyanagi, Y., and Chen, I. S. Y. (1988). High efficiency transfection of primary human lymphocytes and studies of gene expression. Oncogene 3, 123-128.
3. Chao, B. H., Costopoulos, D. S., Curiel, T. J., Bertonis, J. M., Chisholm, P., Williams, C., Schooley, R. T., Rosa, J. J., Fisher, R. A., and Maraganore, J. M. (1989). A 11 3-amino acid fragment of CD4 produced in Escherichia coli blocks human immunodeficiency virus-induced cell fusion. J. Biol. Chem. 264, 5812-5817.
4. Countryman, J., Jenson, H., Seibl, R., Wolf, H., and Miller, G. (1987). Polymorphic proteins encoded within BZLF1 of defective and standard. Epstein-Barr viruses disrupt latency. J. Virol. 61, 3672-3679.
5. Curiel, D. T., Wagner, E., Cotten, M., Birnstiel, M. L., Agarwal, S., Li, C.-M., Loechel, S., and Hu, P.-C. (1992). High-efficiency gene transfer mediated by adenovirus coupled to DNA-polvlysine complexes. Hum. Gene Ther. 3, 147-154.
6. Curiel, T. J., Wong, J. T., Gorzcyca, P. F., Schooley, R. T., and Walker, B. D. (1993). CD4+ Human Immunodeficiency virus type 1 (HiV-1) envelope-specific cytotoxic T-lymphocytes derived from the peripheral blood cells of an HIV-1 infected individual. AIDS Bes. Hum. Retroviruses 9, 61-68.
7. deWet, J. R., Wood, K. V., Deluca, M., Helsinki, D. R., and Subra-mani, S. (1987). Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell Biol. 7, 725-737.
8. Freed, E. O., Myers, D. J., and RiSSEr, R. (1989). Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. A Virol. 63, 4670-4675.
9. Fultz, P. N., Nara, P., Barre-Sinoussi, F., Chaput, A., Greenberg, M. L., Muchmore, E., Kieny, M. P., and Girard, M. (1992). Vaccine protection of chimps against challenge with HIV-1 infected peripheral blood mononuclear cells. Science 256, 1687-1690.
10. Ghosh, S. K., Fultz, P. N., Keddie, E., Saag, M. S., Sharp, P. M., Hahn, B. H., and Shaw, G. (1993). A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology 194, 858-864.
11. Gorman, C., Moffat, L., and Howard, B. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell. Biol. 2, 1044-1051.
12. Hu, S. L, Klaniecki, J., Dykers, T., Sridhar, P., and Travis, B. M. (1991). Neutralizing antibodies against HIV-1 BRU and SF2 isolates generated in mice immunized with recombinant vaccinia virus expressing HIV-1 (BRU) envelope glycoproteins and boosted with homologous gp160. AIDS Res. Hum. Retroviruses 7, 615-620.
13. Jerome, K. R., Bu, D., and Finn, D. J. (1992). Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA. Cancer Res. 52, 5985-5990.
14. Lanzavecchia, A. (1 985). Antigen-specific interaction betweenTand B-cells. Nature 314, 537-539.
15. Li, Y., Kappes, J. C., Conway, J. A., Price, R. W., Shaw, G. M., and Hahn, B. H, (1991). Molecular characterization of human immuno deficiency virus type 1 cloned directly from uncultured human brain tissue: Identification of replication-competent and-defective viral genomes, j. Virol. 65, 3973-85.
16. Lim, K., and Chae, C. B. (1 989). A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for J3-galactosidase, BioTechniques 7, 576-579.
17. Lombardi, L., Newcomb, E. W., and Dalla-Favera, R. (1987). Pathogenesis of Burkitt’s lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49, 161-170.
18. MacGregor, G. R., Mogg, A. E., Burke, J. F., and Caskey, C. T. (1987) Histochemical staining of clonal mammalian cell lines expressing E. coli, 3-galactosidase indicates heterogeneous expression of the bacterial gene. Somatic Cell and Molecular Genetics 13(3), 253-265.
19. Malim, M. H., Tiley, L. S., McCarn, D. F., Rusche, J. K., Hauber, J., and Cullen, B. R. (1990). HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60, 675-683.
20. Malim, M. H., and Cullen, B. R. (1991). HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency. Cell 65, 241-248.
21. Marschall, M., Schwarzmann, F., Leser, U., Oker, B., Alliger, P., Mairhofer, H., and Wolf, H. (1991). The BI’LF4 trans-activator of Epstein-Barr virus is modulated by type and differentiation of the host cell. Virology 181, 1 79.
22. Maxwell, I. H., Glode, L. M., and Maxwell, F. (1991). Expression of the diphtheria toxin A-chain coding sequence under the control of promotors and the enhancers from lg genes as a means of directing toxicity to B-lymphoid cells. Cancer Res. 51, 4299-4304.
23. McCutchan, J. H., and Pagano, J. S. (1968). Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethyla-minoethyl-dextran. J. Natl. Cancer Inst. 41, 351-357.
24. Mcfarland, E., Curiel, T. J., Rosandich, M., Schoen, D., Schooley, R. T., and Kuritzkes, D. R. (1993). HIV-1 GAG and ENV-specific cell lines derived from a perinatally infected child. J. Infect. Dis. 167, 719-723.
25. Mosier, D. E., Gulizia, R. J., Baird, S. M., Spector, S., Spector, D., Kipps, T. J., Fox, R. I., Carson, D. a., Richmann, D. D. (1989). Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr. Top. Microbiol Immunol. 152, 195-199.
26. Mosier, D. E. (1990). immunodeficient mice xenografted with human lymphoid cells: New models for in vivo studies of human immunology and infectious diseases. J. Clin. Immunol. 10(4), 185-191.
27. NIH (January 1992). "AIDS Research and Reference Reagent Program Catalogue." NIH Publication No. 92-1536, p. 87.
28. Nio, Y., Shiraishi, T., Imal S., Ohgaki, K., and Tobe, T. (1989). Binding and internalization of human IgG conjugated with melphalan (K18) to human tumor cell lines. Anticancer Res. 9, 59-64.
29. Plank, C., Zatloukal, K., Cohen, m., Mechtler, K., and Wagner, E. (1992). Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem. 3, 533-539.
30. Plata, F., Autran, B., Martins, L. P., Wain-Hobson, S., Raphael, M., Mayaud, C., Denis, M., Guillon, J. M., and Debre, P. (1987). AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348-351.
31. Portico, D. T., Falk, K., Pirruccello, S. J., Nakamine, H., Kleveland, K., Davis, J. R., Okano, M., Taguchi, Y., Sanger, W. G., and Beisel, K. W. (1991), SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humans. Int. J. Cancer 47, 510-517.
32. Schooley, R. T., and Dolin, R. (1990). Epstein-Barr virus (infectious mononucleosis). In "Principles and Practice of Infectious Disease" (G. L. Mandell, R. G. Douglas, and J. E. Bennett, Eds.), pp. 1 172-1 185. Churchill Livingstone, New York.
33. Sugden, B., Marsh, K., and Yates, J. (1985). Avectorthat replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol. Cell Biol. 5, 410-413.
34. Wagner, E., Zenke, M., Cotten, M., Beug, H., and Birnstiel, M. (1990). Transferrin-polycation conjugates as carriers for DNA uptake into cells, Proc. Natl. Acad. Sci. USA 87, 3410-3414.
35. Wagner, E., Cotten, M., Mechtler, K., Kirlappos, H., and Birnstiel, M. L. (1991). DNA-binding transferrin conjugates as functional gene-delivery agents: Synthesis by linkage of polylysine or ethi-dium homodimer to the transferrin carbohydrate moiety. Bioconjugate Chem. 2, 226-231.
36. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T., and Birnstiel, M. L. (1992). Coupling of adenovirus to transferrin-polylysineJDNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. 89, 6099-6103.
37. Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A.G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S., and Schooley, R. T. (1987). HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345-348.
38. Walker, B. D., Flexner, C., Paradis, T. J., Fuller, T. C., Hirsch, M. C., Schooley, R. T., and Moss, B. (1988). HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240, 64-66.
39. Walls, E. V., and Crawford, D. H. (1989). Generation of human B lymphoblastoid cell lines using Epstein-Barr virus. In "Lymphocytes, a Practical Approach" (G, G. B. Klaus, Ed.), pp. 149-162. Oxford Press, London.
40. Yates, J. L., Warren, N., and Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.